Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Conserved Binding Sites01:49

Conserved Binding Sites

4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
2.8K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

726
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
726
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

189
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
189

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing Cross-scale Feature Mutual Information via Heterogeneous Graph Contrastive Learning for Drug-Target Binding Affinity Prediction.

IEEE journal of biomedical and health informatics·2026
Same author

A general strategy for high-efficiency live bacteria imaging and targeted phototherapy.

Chemical science·2026
Same author

Recruitment of the outer-membrane lipoprotein DolP to the division site via anionic phospholipid-mediated diffusion-state switching.

Molecular biology of the cell·2026
Same author

Decoding the human gut bacterial plasmids in colorectal cancer.

Communications biology·2026
Same author

Pharmacological potential of gardoside in anxiety: Behavioral and molecular evidence.

Journal of ethnopharmacology·2026
Same author

Arabidopsis TMPIT/TMEM120/NET29 homologs are required for cell survival, Golgi morphology, and metabolic fluxes of very long-chain fatty acids to waxes and sphingolipids.

Plant physiology and biochemistry : PPB·2026
Same journal

AdaWGAN: Data Augmentation for Few-Shot HD-sEMG Gesture Recognition Using Single-Trial Data.

IEEE journal of biomedical and health informatics·2026
Same journal

NeuroBooster: a domain-informed self-supervised learning paradigm tailored for brain MRI analysis.

IEEE journal of biomedical and health informatics·2026
Same journal

Graph Convolutional Neural Network based Depression Detection using Brain Functional Connectivity Measures.

IEEE journal of biomedical and health informatics·2026
Same journal

Improving Multi-Sensor Non-Invasive Glucose Detection through AI: A Domain Generalization Approach.

IEEE journal of biomedical and health informatics·2026
Same journal

Unmixing the Neck: Accurate Jugular Venous Pulse Detection From Wearable PPG.

IEEE journal of biomedical and health informatics·2026
Same journal

AD-DAE: Alzheimer's Disease Progression Modeling with Unpaired Longitudinal MRI using Diffusion Auto-Encoders.

IEEE journal of biomedical and health informatics·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K

GraphCL-DTA: A Graph Contrastive Learning With Molecular Semantics for Drug-Target Binding Affinity Prediction.

Xinxing Yang, Genke Yang, Jian Chu

    IEEE Journal of Biomedical and Health Informatics
    |January 8, 2024
    PubMed
    Summary
    This summary is machine-generated.

    GraphCL-DTA enhances drug discovery by improving drug-target interaction prediction. This new method uses graph contrastive learning to better represent molecules, boosting prediction accuracy for drug-target binding affinity.

    More Related Videos

    A Protocol for Computer-Based Protein Structure and Function Prediction
    16:41

    A Protocol for Computer-Based Protein Structure and Function Prediction

    Published on: November 3, 2011

    68.7K
    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
    06:50

    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

    Published on: January 26, 2024

    1.9K

    Related Experiment Videos

    Last Updated: Jul 6, 2025

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
    10:21

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

    Published on: February 23, 2024

    2.5K
    A Protocol for Computer-Based Protein Structure and Function Prediction
    16:41

    A Protocol for Computer-Based Protein Structure and Function Prediction

    Published on: November 3, 2011

    68.7K
    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
    06:50

    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

    Published on: January 26, 2024

    1.9K

    Area of Science:

    • Computational chemistry
    • Drug discovery
    • Machine learning

    Background:

    • Drug-target binding affinity prediction is crucial for early drug discovery.
    • Existing computational models struggle with representation learning from molecular graphs and ignore uniformity metrics.
    • Previous methods often rely solely on supervised data, neglecting inherent molecular graph information.

    Purpose of the Study:

    • To introduce GraphCL-DTA, a novel graph contrastive learning framework for drug-target binding affinity prediction.
    • To enhance drug and target representation learning by incorporating molecular semantics and optimizing uniformity.
    • To improve the performance and generalization capability of computational models in drug discovery.

    Main Methods:

    • Developed a graph contrastive learning framework (GraphCL-DTA) utilizing embedding-space data augmentation to preserve molecular graph semantics.
    • Introduced a new loss function to directly optimize the uniformity of drug and target representations.
    • Validated the model on KIBA and Davis datasets, comparing performance against GraphDTA.

    Main Results:

    • GraphCL-DTA demonstrated improved drug-target binding affinity prediction accuracy, with relative improvements of 2.7% on KIBA and 4.5% on Davis compared to GraphDTA.
    • The graph contrastive learning and uniformity function enhanced the quality of drug and target representations without additional supervised data.
    • The proposed modules showed potential for improving generalization in other computational models.

    Conclusions:

    • GraphCL-DTA offers a more effective approach to drug-target binding affinity prediction by leveraging graph contrastive learning and representation uniformity.
    • The framework provides a robust method for learning essential drug representations, outperforming previous models.
    • The GraphCL-DTA modules can be integrated into existing computational models to enhance their predictive power and generalization.